AXON Stock Recent News
AXON LATEST HEADLINES
Axon Enterprise (AXON -1.64%), the leading manufacturer of police body cameras and Taser devices, trades at over $550 per share and is a potential candidate for a stock split.
Some investors downplay the link between politics and investing, and sometimes Capitol Hill events have little impact. But if it were all irrelevant, why would so many members of Congress trade stocks based on the information they receive?
Axon (AXON) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Axon Enterprise (AXON) reachead $554.39 at the closing of the latest trading day, reflecting a -0.34% change compared to its last close.
Axon Enterprise (AXON -4.18%) helps increase the effectiveness of public safety.
Tariffs and the threat trade wars pose on the global economy are weighing on the markets right now. How long this will last and how devastating the impact will be on businesses has many investors hitting the panic button.
Local governments are expected to increase spending on public safety in 2025, particularly on AI and emerging technologies, which benefits Axon. Axon is a dominant player in the public safety market, with a strong lead in body cams and CEDs (TASERs) and is building a robust ecosystem of integrated solutions. The company reported strong fourth-quarter 2024 results, indicating a healthy business and future potential revenue streams.
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the ZAP-Axon® Radiosurgery Planning System*, an entirely new software platform dedicated to the company's ZAP-X® Gyroscopic Radiosurgery® system. Designed to simplify, accelerate, and enhance treatment planning, Axon aims to set new benchmarks in world-class radiosurgery brain tumor treatments. Axon is currently pending FDA 510(k) clearance and is expected to b.
SCOTTSDALE, Ariz. , March 7, 2025 /PRNewswire/ -- Axon Enterprise, Inc. (Nasdaq: AXON) ("Axon") announced today that it has entered into separate, privately negotiated exchange agreements with certain holders of its 0.50% convertible senior notes due 2027 (the "Notes").
AXON prices senior unsecured notes worth $1,750 million in aggregate principal amount. The net proceeds will pay down part of its borrowings and meet general corporate purposes.